Desitin Arzneimittel GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Desitin Arzneimittel GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014096
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Desitin Arzneimittel GmbH (Desitin), formerly Desitin Compagnie mbH is a healthcare products provider that offers therapeutic products. The company develops and markets products for the treatment of neurological and psychiatric illnesses. It provides products for various therapeutic areas such as Parkinson’s disease, epilepsy, dystonia, actinic keratosis, and spasticity. Desitin offers ameluz, apydan, clarium, diacomit, isicom, lamotrigin destin, ospolot, and other products. The company distributes its products to customers and also through a network of distributors across Europe. It operates through physicians, pharmacists, patients and families to provide services as product support. The company has presence in Denmark, Sweden, Norway, Switzerland, the Czech Republic, Slovakia, Romania, and other countries. Desitin is headquartered in Hamburg, Germany.

Desitin Arzneimittel GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Licensing Agreements 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 12
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 13
Desitin Arzneimittel GmbH – Key Competitors 14
Desitin Arzneimittel GmbH – Key Employees 15
Desitin Arzneimittel GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Desitin Arzneimittel GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Advicenne Pharma Enters into Licensing Agreement with Desitin 12
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 13
Desitin Arzneimittel GmbH, Key Competitors 14
Desitin Arzneimittel GmbH, Key Employees 15
Desitin Arzneimittel GmbH, Subsidiaries 16

★海外企業調査レポート[Desitin Arzneimittel GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Takeuchi Mfg. Co Ltd:企業の戦略・SWOT・財務情報
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Duke University:企業のM&A・事業提携・投資動向
    Duke University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Duke University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Ambac Financial Group, Inc.:企業の戦略・SWOT・財務分析
    Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Independent Order of Foresters:企業の戦略的SWOT分析
    The Independent Order of Foresters - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析
    OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Terramin Australia Ltd:企業の戦略・SWOT・財務分析
    Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Perdana Petroleum Bhd (PERDANA):企業の財務・戦略的SWOT分析
    Perdana Petroleum Bhd (PERDANA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Coutts & Co.:企業の戦略・SWOT・財務情報
    Coutts & Co. - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hotel Properties Ltd:企業の戦略・SWOT・財務情報
    Hotel Properties Ltd - Strategy, SWOT and Corporate Finance Report Summary Hotel Properties Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Swissport International Ltd.:企業の戦略・SWOT・財務情報
    Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Toshiba Corporation:企業のM&A・事業提携・投資動向
    Toshiba Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Toshiba Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Globe Telecom Inc (GLO):企業の財務・戦略的SWOT分析
    Globe Telecom Inc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Quadra – Power Generation:発電所・企業SWOT分析
    Quadra - Power Generation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Coherus BioSciences Inc (CHRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Schindler Holding Ltd.:戦略・SWOT・企業財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Grunenthal GmbH:企業の戦略的SWOT分析
    Grunenthal GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Xenon Pharmaceuticals Inc (XENE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • Oxford Immunotec Ltd-医療機器分野:企業M&A・提携分析
    Summary Oxford Immunotec Ltd (Oxford Immunotec) is a medical device company that develops and commercializes proprietary tests. The company provides international T cell measurement products including T-Cell Xtend and T-SPOT. Its T-SPOT.TB test diagnoses both latent TB infection and active disease b …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆